Personalized Medicine Market Size, Share, Trend, Industry Analysis Report By Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Others), By End Use, By Region

Description

List of Tables

The personalized medicine market size is expected to reach USD 1,300.20 billion by 2034, according to a new study by Polaris Market Research. The report "Personalized Medicine Market Size, Share, Trend, Industry Analysis Report By Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Others), By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The personalized medicine market focuses on tailoring medical treatment to the individual characteristics of each patient, using genetic, environmental, and lifestyle data to guide clinical decisions. Rapid advances in genomic sequencing, molecular diagnostics, and bioinformatics have transformed traditional healthcare by enabling predictive, preventive, and precisely targeted interventions. The integration of biomarker-based therapies into clinical practice is reshaping treatment protocols across oncology, neurology, and cardiology. Increasing emphasis on value-based care is accelerating demand for targeted drugs that minimize adverse effects and improve therapeutic outcomes. The growth in direct-to-consumer genetic testing and increasing patient awareness is expanding access to customized wellness and preventive strategies.

Pharmaceutical companies are investing in biomarker discovery and companion diagnostics to optimize clinical trial outcomes and regulatory approval efficiency. Market trends include a shift toward multi-omics profiling, AI-powered decision-making tools, and personalized digital therapeutics. Opportunities lie in integrating personalized care models into primary care frameworks and leveraging electronic health records to support clinical-genomic data convergence. Increasing interest from payers in covering precision medicine therapies is creating new commercial pathways.

Public-private partnerships focused on rare disease genomics and stratified medicine initiatives are enhancing innovation pipelines. The convergence of diagnostics, therapeutics, and data science is unlocking the full potential of personalized care, making it a central pillar of modern medicine. Growing acceptance of personalized nutrition and microbiome-focused interventions also signals a broader shift toward holistic health management. The personalized medicine market is expected to evolve rapidly in the coming years as stakeholders align clinical utility, technological capabilities, and regulatory support to advance individualized healthcare solutions.

Personalized Medicine Market Report Highlights

By product, the personalized nutrition & wellness segment accounted for ~33% of the revenue share in 2024. Growing consumer awareness about preventive healthcare and lifestyle-related diseases has increased the demand for tailored nutrition and wellness solutions.

Based on end use, the hospitals segment accounted for the largest share in 2024. Advanced infrastructure and broader access to molecular testing platforms make hospitals key centers for implementing precision medicine.

North America accounted for ~40% of the revenue share in 2024 due to high adoption of genomic technologies, advanced diagnostics, and precision therapeutics across clinical settings.

The personalized medicine market in Asia Pacific is expected to register a CAGR of 12.2% from 2025 to 2034, as surging demand for tailored healthcare in densely populated countries, rising healthcare spending, and growing access to genomic services are driving expansion.

A few global key players include Abbott; ASURAGEN, INC.; Biogen; Celera Diagnostics LLC.; Dako A/S; Danaher Corporation (Cepheid, Inc.); Decode Genetics, Inc.; Exact Sciences Corporation; Exagen Inc.; GE Healthcare; Genelex; Illumina, Inc.; Precision Biologics; and QIAGEN.

Polaris Market Research has segmented the personalized medicine market report on the basis of product, end use, and region:

By Product Outlook (Revenue, USD Billion, 2020-2034)

Personalized Medicine Diagnostics

Genetic Testing

Direct-To-Consumer (DTC) Diagnostics

Others

Personalized Medicine Therapeutics

Pharmaceutical

Genomic Medicine

Medical Devices

Personalized Medical Care

Personalized Nutrition & Wellness

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Hospitals

Diagnostic Centers

Research & Academic Institutes

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Product Code: PM5986

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Personalized Medicine Market Insights

4.1. Personalized Medicine Market - Market Snapshot
4.2. Personalized Medicine Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing Prevalence of Chronic and Rare Diseases
  - 4.2.1.2. Increased Investment in R&D by Pharma and Biotech Firms
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High development and diagnostic costs
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Personalized Medicine Market Application Trends
4.6. Value Chain Analysis

5. Global Personalized Medicine Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
5.3. Personalized Medicine Diagnostics
- 5.3.1. Global Personalized Medicine Market, by Personalized Medicine Diagnostics, by Region, 2020-2034 (USD Billion)
- 5.3.2. Genetic Testing
  - 5.3.2.1. Global Personalized Medicine Market, by Genetic Testing, by Region, 2020-2034 (USD Billion)
- 5.3.3. Direct-To-Consumer (DTC) Diagnostics
  - 5.3.3.1. Global Personalized Medicine Market, by Direct-To-Consumer (DTC) Diagnostics, by Region, 2020-2034 (USD Billion)
- 5.3.4. Others
  - 5.3.4.1. Global Personalized Medicine Market, by Others, by Region, 2020-2034 (USD Billion)
5.4. Personalized Medicine Therapeutics
- 5.4.1. Global Personalized Medicine Market, by Personalized Medicine Therapeutics, by Region, 2020-2034 (USD Billion)
- 5.4.2. Pharmaceutical
  - 5.4.2.1. Global Personalized Medicine Market, by Pharmaceutical, by Region, 2020-2034 (USD Billion)
- 5.4.3. Genomic Medicine
  - 5.4.3.1. Global Personalized Medicine Market, by Genomic Medicine, by Region, 2020-2034 (USD Billion)
- 5.4.4. Medical Devices
  - 5.4.4.1. Global Personalized Medicine Market, by Medical Devices, by Region, 2020-2034 (USD Billion)
5.5. Personalized Medical Care
- 5.5.1. Global Personalized Medicine Market, by Personalized Medical Care, by Region, 2020-2034 (USD Billion)
5.6. Personalized Nutrition & Wellness
- 5.6.1. Global Personalized Medicine Market, by Others, by Personalized Nutrition & Wellness, 2020-2034 (USD Billion)

6. Global Personalized Medicine Market, by End Use

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
6.3. Hospitals
- 6.3.1. Global Personalized Medicine Market, by Hospitals, by Region, 2020-2034 (USD Billion)
6.4. Diagnostic Centers
- 6.4.1. Global Personalized Medicine Market, by Diagnostic Centers, by Region, 2020-2034 (USD Billion)
6.5. Research & Academic Institutes
- 6.5.1. Global Personalized Medicine Market, by Research & Academic Institutes, by Region, 2020-2034 (USD Billion)
6.6. Others
- 6.6.1. Global Personalized Medicine Market, by Othersr, by Region, 2020-2034 (USD Billion)

7. Global Personalized Medicine Market, by Geography

7.1. Key Findings
7.2. Introduction
- 7.2.1. Personalized Medicine Market Assessment, By Geography, 2020-2034 (USD Billion)
7.3. Personalized Medicine Market - North America
- 7.3.1. North America: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
- 7.3.2. North America: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
- 7.3.3. Personalized Medicine Market - U.S.
  - 7.3.3.1. U.S.: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  - 7.3.3.2. U.S.: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
- 7.3.4. Personalized Medicine Market - Canada
  - 7.3.4.1. Canada: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  - 7.3.4.2. Canada: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
- 7.3.5. Personalized Medicine Market - Mexico
  - 7.3.5.1. Mexico: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  - 7.3.5.2. Mexico: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
7.4. Personalized Medicine Market - Europe
- 7.4.1. Europe: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
- 7.4.2. Europe: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
- 7.4.3. Personalized Medicine Market - UK
  - 7.4.3.1. UK: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  - 7.4.3.2. UK: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
- 7.4.4. Personalized Medicine Market - France
  - 7.4.4.1. France: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  - 7.4.4.2. France: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
- 7.4.5. Personalized Medicine Market - Germany
  - 7.4.5.1. Germany: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  - 7.4.5.2. Germany: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
- 7.4.6. Personalized Medicine Market - Italy
  - 7.4.6.1. Italy: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  - 7.4.6.2. Italy: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
- 7.4.7. Personalized Medicine Market - Spain
  - 7.4.7.1. Spain: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  - 7.4.7.2. Spain: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
- 7.4.8. Personalized Medicine Market - Netherlands
  - 7.4.8.1. Netherlands: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  - 7.4.8.2. Netherlands: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
- 7.4.9. Personalized Medicine Market - Russia
  - 7.4.9.1. Russia: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  - 7.4.9.2. Russia: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
- 7.4.10. Personalized Medicine Market - Rest of Europe
  - 7.4.10.1. Rest of Europe: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  - 7.4.10.2. Rest of Europe: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
7.5. Personalized Medicine Market - Asia Pacific
- 7.5.1. Asia Pacific: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
- 7.5.2. Asia Pacific: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
- 7.5.3. Personalized Medicine Market - China
  - 7.5.3.1. China: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  - 7.5.3.2. China: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
- 7.5.4. Personalized Medicine Market - India
  - 7.5.4.1. India: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  - 7.5.4.2. India: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
- 7.5.5. Personalized Medicine Market - Malaysia
  - 7.5.5.1. Malaysia: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  - 7.5.5.2. Malaysia: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
- 7.5.6. Personalized Medicine Market - Japan
  - 7.5.6.1. Japan: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  - 7.5.6.2. Japan: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
- 7.5.7. Personalized Medicine Market - Indonesia
  - 7.5.7.1. Indonesia: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  - 7.5.7.2. Indonesia: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
- 7.5.8. Personalized Medicine Market - South Korea
  - 7.5.8.1. South Korea: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  - 7.5.8.2. South Korea: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
- 7.5.9. Personalized Medicine Market - Australia
  - 7.5.9.1. Australia: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  - 7.5.9.2. Australia: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
- 7.5.10. Personalized Medicine Market - Rest of Asia Pacific
  - 7.5.10.1. Rest of Asia Pacific: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  - 7.5.10.2. Rest of Asia Pacific: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
7.6. Personalized Medicine Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
- 7.6.2. Middle East & Africa: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
- 7.6.3. Personalized Medicine Market - Saudi Arabia
  - 7.6.3.1. Saudi Arabia: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  - 7.6.3.2. Saudi Arabia: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
- 7.6.4. Personalized Medicine Market - UAE
  - 7.6.4.1. UAE: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  - 7.6.4.2. UAE: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
- 7.6.5. Personalized Medicine Market - Israel
  - 7.6.5.1. Israel: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  - 7.6.5.2. Israel: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
- 7.6.6. Personalized Medicine Market - South Africa
  - 7.6.6.1. South Africa: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  - 7.6.6.2. South Africa: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
- 7.6.7. Personalized Medicine Market - Rest of Middle East & Africa
  - 7.6.7.1. Rest of Middle East & Africa: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  - 7.6.7.2. Rest of Middle East & Africa: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
7.7. Personalized Medicine Market - Latin America
- 7.7.1. Latin America: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
- 7.7.2. Latin America: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
- 7.7.3. Personalized Medicine Market - Brazil
  - 7.7.3.1. Brazil: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  - 7.7.3.2. Brazil: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
- 7.7.4. Personalized Medicine Market - Argentina
  - 7.7.4.1. Argentina: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  - 7.7.4.2. Argentina: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)
- 7.7.5. Personalized Medicine Market - Rest of Latin America
  - 7.7.5.1. Rest of Latin America: Personalized Medicine Market, by Product, 2020-2034 (USD Billion)
  - 7.7.5.2. Rest of Latin America: Personalized Medicine Market, by End Use, 2020-2034 (USD Billion)

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. Abbott
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
9.2. ASURAGEN, INC.
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
9.3. Biogen
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
9.4. Celera Diagnostics LLC.
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
9.5. Dako A/S
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
9.6. Danaher Corporation (Cepheid, Inc.)
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
9.7. Decode Genetics, Inc.
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
9.8. Exact Sciences Corporation
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
9.9. Exagen Inc.
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
9.10. GE Healthcare
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
9.11. Genelex
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
9.12. Illumina, Inc.
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Recent Development
9.13. Precision Biologics
- 9.13.1. Company Overview
- 9.13.2. Financial Performance
- 9.13.3. Product Benchmarking
- 9.13.4. Recent Development
9.14. QIAGEN
- 9.14.1. Company Overview
- 9.14.2. Financial Performance
- 9.14.3. Product Benchmarking
- 9.14.4. Recent Development